Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;1(1):50-3.
doi: 10.4103/2229-516X.81982.

Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective

Ruchika Nandha  1 , Anita Gupta, Arif Hashmi
Affiliations

Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective

Ruchika Nandha et al. Int J Appl Basic Med Res. 2011 Jan.

Abstract

Background: Cutaneous manifestations of adverse drug reactions are a common occurrence and need to be differentiated from other causes of similar manifestations. Active search is essential for identification of these as patients may tend to downplay the causal association between drug use and the subsequent cutaneous manifestation.

Purpose: To study the incidence of Cutaneous Adverse Drug Reactions (CADRs) in a tertiary care teaching hospital in North India.

Methods: A prospective, observational study was conducted over a period of 6 months; using self-reporting method for selection of cases. The CADRs were graded as definite, possible and probable.

Results: During the study period, 91 cases of CADRs were observed. Maximum incidence of CADRs was seen with antimicrobials (48.30%), followed by nonsteroidal anti-inflammatory drugs (21.90%). Maculopapular rash was the most common cutaneous manifestation of ADRs (42.85%).

Conclusion: CADRs are a common occurrence and awareness about the same is essential for diagnosis and prevention.

Keywords: Cutaneous adverse drug reactions; drug rash; drug reaction; pharmacovigilance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Relation of frequency of CADRs with age
Figure 2
Figure 2
Drug groups causing CADRs
See this image and copyright information in PMC

References

    1. Nerurkar RP, Nadkar MY, Bichile SK. Need for monitoring adverse drug reactions. J Assoc Physicians India. 1998;46:673–4. - PubMed
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5. - PubMed
    1. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital--their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687–92. - PubMed
    1. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001;137:765–70. - PubMed
    1. Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India. Indian J Dermatol Venereol Leprol. 2004;70:20–4. - PubMed